Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stabilization and depot neuroleptic dosages

P Weiden1, N R Schooler, J B Severe

  • 1St. Luke's/Roosevelt Hospital Center, New York, NY 10012.

Psychopharmacology Bulletin
|January 1, 1993
PubMed
Summary

Schizophrenia stabilization using fluphenazine decanoate (FZD) shows stable doses lead to faster stabilization but not necessarily better outcomes. Some patients on unstable lowering doses experienced longer stabilization times.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers.

Journal of developmental and behavioral pediatrics : JDBP·2001
Same author

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.

Journal of the American Academy of Child and Adolescent Psychiatry·2001
Same author

Multimodal treatment of ADHD in the MTA: an alternative outcome analysis.

Journal of the American Academy of Child and Adolescent Psychiatry·2001
Same author

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Journal of the American Academy of Child and Adolescent Psychiatry·2001
Same author

Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.

Journal of the American Academy of Child and Adolescent Psychiatry·2001
Same author

Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.

Journal of the American Academy of Child and Adolescent Psychiatry·2001

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Psychology

Background:

  • The stabilization phase of schizophrenia treatment remains poorly understood.
  • Effective long-acting injectable antipsychotics like fluphenazine decanoate (FZD) are crucial for schizophrenia maintenance therapy.

Purpose of the Study:

  • To investigate fluphenazine decanoate (FZD) prescribing patterns during the stabilization phase in schizophrenia patients.
  • To identify distinct dosage patterns and their association with stabilization time and treatment response.

Main Methods:

  • Analysis of dosage data from 208 successfully stabilized patients in the Treatment Strategies in Schizophrenia (TSS) study.
  • Categorization of patients into five hypothesized dosage pattern groups: STABLE HIGH, STABLE INTERMEDIATE, STABLE LOW, UNSTABLE RAISING, and UNSTABLE LOWERING.

Related Experiment Videos

  • Evaluation of dosage patterns against predictive and outcome variables.

    • Main Results:

    • 82% of subjects fit into one of the five hypothesized dosage pattern groups.
    • All patient groups demonstrated improvement during stabilization.
    • Stable dose groups achieved stabilization faster than unstable groups, but without a superior medication response.
    • An initial high-dose strategy (loading dose) in the UNSTABLE LOWERING group was paradoxically linked to longer stabilization.

    Conclusions:

    • Dosage stability, rather than specific dosage levels, appears to influence the speed of stabilization in schizophrenia.
    • The findings suggest that a "loading dose" strategy with fluphenazine decanoate may prolong stabilization time.
    • Further research is needed to optimize FZD dosing strategies for efficient schizophrenia stabilization.